Dubai Health and Johnson & Johnson Medtech have signed a Memorandum of Understanding (MoU) to establish a collaboration framework to advance professional education, advance sustainability initiatives and support digital innovation in healthcare.
This collaboration is structured around three core pillars. The first focuses on professional education and development through customized training programs and train-the-trainer initiatives. Second, we promote sustainable development by expanding recycling programs across selected hospitals. Third, we support the implementation of a digital ecosystem that enables surgical video capture, secure content sharing, collaborative case planning, and telepresence-enabled remote collaboration and education.
Dr. Hanan Al Suwaidi said, “This strategic partnership with Johnson & Johnson MedTech reflects our commitment to healthcare excellence through purpose-driven partnerships. Guided by our vision to advance human health, we are building a framework to strengthen professional education, promote sustainability, and support digital innovation across an integrated academic health system.”
Dr. Tarek Fathy said, “This partnership marks an important milestone in advancing clinical practice across Dubai Health by integrating advanced digital technologies into the surgical environment and clinical education. This will improve the accuracy of medical decision-making, strengthen multidisciplinary team capabilities, and ultimately contribute to improved patient outcomes.”
“Dubai Health’s ‘Patients First’ promise reflects the same principle that guides everything we do at Johnson & Johnson Medtech: putting patients’ needs first and foremost,” said Prosun Niyogi. “This partnership will open a new model for professional education. “We will be able to advance sustainable medical practices and connect clinicians through digital innovation, all in the service of one goal: removing restrictions on all lives and changing the trajectory of health for communities across the UAE and beyond.”
This collaboration reflects a shared commitment to driving meaningful advances in healthcare through knowledge exchange, innovation and strategic partnerships, ultimately supporting better outcomes for patients and communities.
The MoU was signed by Dr. Hanan Al Suwaidi, Deputy CEO and Chief Academic Officer of Dubai Health and President of Mohammed Bin Rashid University of Medicine and Health Sciences (MBRU), and Prosun Niyogi, Vice President and General Manager, Surgical Emerging Markets, on behalf of Johnson & Johnson MedTech. The signing was attended by Dr Tarek Fathy, Chief Clinical Officer of Dubai Health.
